GlassScriptPhysician profile
Abid N Chaudhry
NPI 1891875126
$10,589.02
in general payments reported to CMS, 2019-2025
17 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,464 · 2020: $470 · 2021: $2,667 · 2022: $1,634 · 2023: $2,757 · 2024: $1,101 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,331 · Food and Beverage: $1,876 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,331.08 |
| Food and Beverage | $1,876.19 |
| Long Term Medical Supply Or Device Loan | $146.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,203.62 | 2019-2025 | Salvation, Hoffmann, Augment Injectable |
| Zimmer Biomet Holdings, INC. | $1,213.69 | 2020-2023 | Stratum Foot Plating System |
| Integra Lifesciences Corporation | $1,205.53 | 2019-2025 | Micromatrix, Integra, Primatrix |
| Treace Medical Concepts, INC. | $844.06 | 2021-2022 | |
| Smith+Nephew, INC. | $398.55 | 2021-2022 | |
| Paragon 28, INC. | $179.37 | 2020-2023 | Gorilla |
| Nevro Corp. | $135.40 | 2022 | |
| Horizon Therapeutics Plc | $114.99 | 2021 | |
| Cardiovascular Systems INC. | $90.40 | 2021-2022 | |
| Angiodynamics, INC. | $77.98 | 2022 | |
| Access Pro Medical, LLC | $37.50 | 2025 | Matriderm |
| Organogenesis INC. | $26.94 | 2025 | Cygnus Dual |
| Wright Medical Technology, INC. | $17.14 | 2019 | |
| Heron Therapeutics, INC. | $15.60 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.16 | 2023 | Nuzyra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $14.09 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abid Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.